The centralized procurement of medical consumables continues to deepen, and the procurement of low-value consumables is blooming everywhere

Low-value medical consumables are generally divided into medical sanitary materials and dressings, injection puncture, medical polymer materials, medical disinfection, anesthesia consumables, operating room consumables and medical technology consumables
.
At present, affected by the continuous expansion of centralized procurement in terms of quantity, product range and scale, low-value consumables with low unit prices but large quantities are also being continuously included in volume procurement
.
Recently, the Office of the Purchasing Alliance of Henan Public Medical Institutions issued the "Announcement on Issues Concerning the Procurement Documents of the Alliance of Public Medical Institutions of Henan Province and the Negotiation of Quotation and Price Bargaining" (hereinafter referred to as the "Announcement")
.
The "Announcement" proposes that the province's three-level public medical institutions form a public medical institution procurement alliance to carry out centralized procurement of hemostatic materials, anti-adhesion materials, and dural (spine) membrane medical consumables
.
Among them, the centralized purchase of hemostatic materials and medical consumables includes hemostatic materials for body use, hemostatic materials for body surface, special hemostatic sponge for ear, nose and throat, and medical glue
.
Anti-adhesion materials are purchased in a centralized quantity for anti-adhesion glue, anti-adhesion liquid, and anti-adhesion film
.
Dural (spine) membrane medical consumables are purchased in a centralized quantity, including dural (spine) membranes and dural (spine) membrane auxiliary consumables
.
Earlier, the Taiyuan Medical Insurance Bureau also announced that starting from November 1, the prices of three types of medical consumables will be reduced by an average of 55.
75%
.
It is reported that this is a centralized procurement of low-value medical consumables from Taiyuan-Jinzhong-Xinzhou-Lüliang medical institutions led by Taiyuan City
.
The centralized procurement project carried out by this organization involves 3 types of medical consumables: urinary catheters, urinary catheterization kits, and needle-free airtight infusion connectors
.
In addition, as early as April this year, Changsha City also started the collection of low-value medical consumables and test reagents
.
It is reported that the scope of this centralized procurement is very large, except for the thirteen categories of consumables organized and implemented by Hunan Province, and the centralized procurement projects (such as nucleic acid test reagents, etc.
) organized by the Provincial Medical Insurance Bureau as specified in the document.
Low-value medical consumables and test reagents are included in the scope of centralized procurement
.
It is worth noting that as provinces and cities have successively started to purchase low-value consumables, the prices of related products have also dropped significantly.

.
For example, in June this year, all procurement entities in Hebei Province implemented the results of the centralized procurement of disposable infusion sets and intravenous indwelling needles organized by Hebei Province
.
It is estimated that the average drop rate of disposable infusion sets is 75.
38%, and the highest drop rate is 90%.
It is estimated that the annual medical cost can be saved by 393 million yuan
.
The average drop of intravenous indwelling needles is 78.
42%, and the highest drop is 89.
82%.
It is estimated that the annual medical cost can be saved by 254 million yuan
.
The analysis believes that compared with high-value medical consumables such as cardiac intervention, artificial joints, and other organ intervention replacements, although the individual prices of low-value medical consumables are not high, they are widely used and lower prices can benefit more patients
.
However, from pharmaceuticals to consumables, the exploration pace of volume procurement at the national and local levels is accelerating, and price moisture is constantly being squeezed out.
The industry has also pointed out that whether it is a pharmaceutical company or a machinery company, it is constantly squeezing profits in centralized procurement.
Under the circumstances, it is necessary to accelerate innovation and find new profit growth points to enhance competitiveness
.